A Study of trastuzumab deruxtecan for patients with advanced HER2-positive gastric or gastroesophageal junction adenocarcinoma who have received a prIor Trastuzumab-based regimen accompanied by a disease registry of patients treated with conventional therapies (PROSPERITY)

  • Ghanem, Riad (Researcher)
  • Kausche, Lea Elisabeth (Researcher)
  • Klein, Katharina (Researcher)
  • Kovacsova, Judita (Researcher)
  • Krenosz, K. J. (Researcher)
  • Krivic, Denis (Researcher)
  • Kühr, Thomas (Researcher)
  • Lichtenauer, Nina (Researcher)
  • Popp, Henning Detlef (Researcher)
  • Schmitt, Clemens (Researcher)
  • Schneeweiß, Bruno (Researcher)
  • Schwarz, Heike (Researcher)
  • Solomianyi, Oleksii (Researcher)
  • Stegemann, Maike (Researcher)
  • Piringer, Gudrun (PI)

Project: Clinical studies › Clinical Study (Funded research)

Project Details

Description

A Study of trastuzumab deruxtecan for patients with advanced HER2-positive gastric or gastroesophageal junction adenocarcinoma who have received a prIor Trastuzumab-based regimen accompanied by a disease registry of patients treated with conventional therapies (PROSPERITY)
StatusActive
Effective start/end date21.08.2024 → 31.12.2027

Fields of science

  • 302024 Haematology
  • 302055 Oncology